These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

948 related items for PubMed ID: 8550992

  • 1. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A, Rudolph G, Sauer P, Theilmann L.
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [Abstract] [Full Text] [Related]

  • 2. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A.
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract] [Full Text] [Related]

  • 3. Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis.
    Rost D, Rudolph G, Kloeters-Plachky P, Stiehl A.
    Hepatology; 2004 Sep; 40(3):693-8. PubMed ID: 15349909
    [Abstract] [Full Text] [Related]

  • 4. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
    Rudolph G, Endele R, Senn M, Stiehl A.
    Hepatology; 1993 Jun; 17(6):1028-32. PubMed ID: 8514251
    [Abstract] [Full Text] [Related]

  • 5. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
    Beuers U.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM, Schrumpf E.
    Tidsskr Nor Laegeforen; 1997 Sep 30; 117(23):3370-3. PubMed ID: 9411890
    [Abstract] [Full Text] [Related]

  • 7. New therapeutical indications of ursodeoxycholic acid.
    Copaci I, Micu L, Iliescu L, Voiculescu M.
    Rom J Gastroenterol; 2005 Sep 30; 14(3):259-66. PubMed ID: 16200237
    [Abstract] [Full Text] [Related]

  • 8. Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture.
    Fracchia M, Soubrane O, Houssin D, Galatola G.
    Ital J Gastroenterol; 1995 Sep 30; 27(8):430-5. PubMed ID: 8775469
    [Abstract] [Full Text] [Related]

  • 9. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM, Campbell GR, Burke AF, Maguire OC, Rowlands BJ, FitzGerald MX, Hegarty JE.
    Eur J Gastroenterol Hepatol; 1996 May 30; 8(5):477-83. PubMed ID: 8804877
    [Abstract] [Full Text] [Related]

  • 10. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE.
    Liver Transpl Surg; 1998 Sep 30; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [Abstract] [Full Text] [Related]

  • 11. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI, Serrano MA, Monte MJ, Jimenez S, Hernandez B, Marin JJ.
    J Pharmacol Exp Ther; 2005 Feb 30; 312(2):751-8. PubMed ID: 15452192
    [Abstract] [Full Text] [Related]

  • 12. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, Zatloukal K, Liu J, Waalkes MP, Cover C, Denk H, Hofmann AF, Jaeschke H, Trauner M.
    Gastroenterology; 2006 Feb 30; 130(2):465-81. PubMed ID: 16472600
    [Abstract] [Full Text] [Related]

  • 13. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
    El-Mir MY, Monte MJ, Morales AI, Arevalo M, Serrano MA, Marin JJ.
    Hepatology; 1997 Sep 30; 26(3):527-36. PubMed ID: 9303479
    [Abstract] [Full Text] [Related]

  • 14. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Paumgartner G, Beuers U.
    Hepatology; 2002 Sep 30; 36(3):525-31. PubMed ID: 12198643
    [Abstract] [Full Text] [Related]

  • 15. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K, Epple-Gutsfeld M, Leiss O.
    Gastroenterology; 1984 Jul 30; 87(1):136-43. PubMed ID: 6724256
    [Abstract] [Full Text] [Related]

  • 16. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid.
    Rudolph G, Kloeters-Plachky P, Rost D, Stiehl A.
    Eur J Gastroenterol Hepatol; 2007 Jun 30; 19(6):487-91. PubMed ID: 17489059
    [Abstract] [Full Text] [Related]

  • 17. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD, Lacerda MA, Jorgensen RA, DeSotel CK, Batta AK, Salen G, Dickson ER, Rossi SS, Hofmann AF.
    Am J Gastroenterol; 1998 Sep 30; 93(9):1498-504. PubMed ID: 9732932
    [Abstract] [Full Text] [Related]

  • 18. [Cholestasis: drug therapy].
    Leuschner U.
    Praxis (Bern 1994); 1998 Nov 11; 87(46):1532-6. PubMed ID: 9857764
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K, Angelin B, Leijd B, Einarsson K.
    Gastroenterology; 1983 Dec 11; 85(6):1248-56. PubMed ID: 6628924
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.